Becton Dickinson PE Ratio 2006-2018 | BDX

Current and historical p/e ratio for Becton Dickinson (BDX) from 2006 to 2018. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Becton Dickinson PE ratio as of November 15, 2018 is 21.44.
Becton Dickinson PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2018-11-15 240.04 222.26
2018-09-30 261.00 $1.08 241.67
2018-06-30 239.56 $2.32 103.26
2018-03-31 216.00 $-0.46 0.00
2017-12-31 212.65 $1.31 162.33
2017-09-30 193.99 $4.65 41.72
2017-06-30 192.46 $3.50 54.99
2017-03-31 180.26 $6.05 29.80
2016-12-31 162.04 $6.03 26.87
2016-09-30 175.14 $4.51 38.83
2016-06-30 164.65 $5.26 31.30
2016-03-31 146.82 $3.75 39.15
2015-12-31 148.35 $3.27 45.37
2015-09-30 127.18 $3.41 37.29
2015-06-30 135.19 $4.10 32.97
2015-03-31 136.46 $5.46 24.99
2014-12-31 131.70 $5.83 22.59
2014-09-30 107.25 $6.00 17.87
2014-06-30 110.96 $4.93 22.51
2014-03-31 109.31 $4.80 22.77
2013-12-31 102.68 $4.74 21.66
2013-09-30 92.48 $6.50 14.23
2013-06-30 90.93 $7.47 12.17
2013-03-31 87.52 $7.54 11.61
2012-12-31 71.17 $7.54 9.44
2012-09-30 71.05 $5.62 12.64
2012-06-30 67.21 $5.55 12.11
2012-03-31 69.39 $5.49 12.64
2011-12-31 66.37 $5.48 12.11
2011-09-30 64.73 $5.63 11.50
2011-06-30 75.69 $5.95 12.72
2011-03-31 69.60 $5.71 12.19
2010-12-31 73.50 $5.57 13.20
2010-09-30 64.12 $5.51 11.64
2010-06-30 58.20 $5.12 11.37
2010-03-31 67.40 $5.22 12.91
2009-12-31 67.20 $5.04 13.33
2009-09-30 59.15 $5.00 11.83
2009-06-30 60.19 $4.83 12.46
2009-03-31 56.48 $4.62 12.23
2008-12-31 57.15 $4.65 12.29
2008-09-30 66.72 $4.46 14.96
2008-06-30 67.36 $4.33 15.56
2008-03-31 70.89 $4.11 17.25
2007-12-31 68.79 $3.97 17.33
2007-09-30 67.31 $3.46 19.45
2007-06-30 60.92 $3.15 19.34
2007-03-31 62.67 $3.00 20.89
2006-12-31 56.98 $2.65 21.50
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $62.942B $15.983B
Becton, Dickinson & Company is a global medical technology company that is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD leads in patient and health care worker safety and the technologies that enable medical research and clinical laboratories. The company provides innovative solutions that help advance medical research and genomics, enhance the diagnosis of infectious disease and cancer, improve medication management, promote infection prevention, equip surgical and interventional procedures, and support the management of diabetes. The company partners with organizations around the world to address some of the most challenging global health issues.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $25.182B 9.62
AmerisourceBergen (ABC) United States $19.381B 13.82
Align Technology (ALGN) United States $17.596B 44.90
Cardinal Health (CAH) United States $17.075B 11.46
Laboratory Of America Holdings (LH) United States $16.534B 14.97
Henry Schein (HSIC) United States $13.024B 21.41
Cooper (COO) United States $12.484B 22.48
DENTSPLY SIRONA (XRAY) United States $8.036B 16.05
West Pharmaceutical Services (WST) United States $7.887B 39.14
Merit Medical Systems (MMSI) United States $3.169B 37.53
Patterson (PDCO) United States $2.400B 16.87
CONMED (CNMD) United States $1.918B 31.85
STAAR Surgical (STAA) United States $1.808B 186.23
Atrion (ATRI) United States $1.343B 38.40
Antares Pharma (ATRS) United States $0.528B 0.00
Invacare (IVC) United States $0.210B 0.00
Lifevantage (LFVN) United States $0.170B 24.10
Endologix (ELGX) United States $0.096B 0.00
Pro-Dex (PDEX) United States $0.058B 26.08
Aceto (ACET) United States $0.058B 0.00
Biolase (BIOL) United States $0.026B 0.00
Retractable Technologies (RVP) United States $0.022B 0.00
Milestone Scientific (MLSS) United States $0.019B 0.00